Saturday 17 October 2026 Export COLL’s income statement to Excel — free account

Collegium Pharmaceutical, Inc.

COLL Healthcare Drug Manufacturers Specialty & Generic

Collegium Pharmaceutical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $780.6 million, up 23.6% from fiscal 2024. In the quarter to June 2026, revenue grew 6.32%, EPS fell 221.1%, free cash flow fell 2.14% and total debt rose 32.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

23.19 0.01 +0.04%

Follow COLL

Alert me

Market cap: $754.6M
P/E: 15.2×
Fwd P/E: 12.5×
Dividend yield: —
F-score: 7/9
Altman Z: 1.58
Beneish M: −3.32
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	18.91	23.15	13.95	23.66
P/S ratio Full definition →		1.46	1.88	1.33	1.45
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		14.08	11.93	18.58	16.48
P/B ratio Full definition →		4.02	4.87	3.40	3.77
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		2.12	2.40	1.79	2.62
EV/EBITDA Full definition →		4.21	4.62	3.44	5.42
EV/Operating CF Full definition →		5.52	5.68	4.30	6.42
EV/FCF Full definition →		(20.36)	(46.03)	(37.04)	(53.00)
Quick Ratio Full definition →		1.19	1.40	1.54	0.74
Current Ratio Full definition →		1.36	1.57	1.71	1.03
Net Debt/EBITDA Full definition →		4.24	3.45	4.17	13.77
Debt/Assets Full definition →		50.28%	48.85%	48.60%	51.11%
Debt/Equity Full definition →		2.94	2.68	2.57	3.50
Asset Turnover Full definition →		0.47	0.47	0.49	0.43
Operating CF/Net income Full definition →		2.49	7.25	3.94	(4.74)
Capex/Depreciation Full definition →		0.00	(0.01)	0.00	(0.01)
Interest Coverage Full definition →		2.85	3.15	1.95	0.19
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		32.05%	32.92%	44.62%	53.33%
Intangible Assets out of Total Assets Full definition →		0.54	0.49	0.46	0.64
Share Based Compensation of Revenue Full definition →		4.69%	4.75%	5.62%	7.25%
Graham Net Nets Full definition →		(0.65)	(0.45)	(0.56)	(1.03)
Graham Number Full definition →		19.03	20.69	22.79	18.19
Earnings Yield Full definition →		5.29%	4.32%	7.17%	4.23%
Free Cash Flow Yield Full definition →		(7.14%)	(2.77%)	(3.62%)	(3.40%)
Revenue per Share Full definition →		6.63	6.48	6.03	6.16
Operating CF per Share Full definition →		2.48	3.88	1.78	2.20
Capex per Share Full definition →		(0.01)	(0.02)	(0.01)	(0.02)
Free Cash Flow per Share Full definition →		2.48	3.86	1.77	2.18
Cash per Share Full definition →		9.68	12.82	13.76	4.60
Shareholders Equity per Share Full definition →		8.70	9.51	9.74	9.61
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		8.70	9.51	9.74	9.61
Free Cash Flow Full definition →		78.25	122.36	56.84	70.83
Working Capital Full definition →		160.94	251.38	310.70	18.15
Capital Expenditures Full definition →		(0.19)	(0.69)	(0.27)	(0.50)
Net Current Asset Value Full definition →		(718.65)	(663.75)	(593.86)	(1,215.87)
EV/EBIT Full definition →		10.24	10.41	7.53	13.45
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		7.04	8.17	5.62	7.46
Other line items
Average Receivables Full definition →		231.20	219.93	228.74	249.06
Average Payables Full definition →		5.39	7.30	12.34	10.07
Average Inventory Full definition →		38.04	38.24	39.98	75.71
Average Assets Full definition →		1,621.24	1,660.21	1,641.67	1,864.21
Average Common Equity Full definition →		254.54	265.26	273.43	272.06

Show all line items

Columns are period end dates

Stockrow Weekly